Exosomes derived from pulmonary metastatic sites enhance osteosarcoma lung metastasis by transferring the miR-194/215 cluster targeting MARCKS

Osteosarcoma, a prevalent primary malignant bone tumor, often presents with lung metastases, severely impacting patient survival rates. Extracellular vesicles, particularly exosomes, play a pivotal role in the formation and progression of osteosarcoma-related pulmonary lesions. However, the communic...

Full description

Saved in:
Bibliographic Details
Published inActa pharmaceutica Sinica. B Vol. 14; no. 5; pp. 2039 - 2056
Main Authors Yu, Pei, Han, Yubao, Meng, Lulu, Tian, Yanyuan, Jin, Zhiwei, Luo, Jun, Han, Chao, Xu, Wenjun, Kong, Lingyi, Zhang, Chao
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier 01.05.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Osteosarcoma, a prevalent primary malignant bone tumor, often presents with lung metastases, severely impacting patient survival rates. Extracellular vesicles, particularly exosomes, play a pivotal role in the formation and progression of osteosarcoma-related pulmonary lesions. However, the communication between primary osteosarcoma and exosome-mediated pulmonary lesions remains obscure, with the potential impact of pulmonary metastatic foci on osteosarcoma progression largely unknown. This study unveils an innovative mechanism by which exosomes originating from osteosarcoma pulmonary metastatic sites transport the miR-194/215 cluster to the primary tumor site. This transportation enhances lung metastatic capability by downregulating myristoylated alanine-rich C-kinase substrate (MARCKS) expression. Addressing this phenomenon, in this study we employ cationic bovine serum albumin (CBSA) to form nanoparticles (CBSA-anta-194/215) electrostatic interaction with antagomir-miR-194/215. These nanoparticles are loaded into nucleic acid-depleted exosomal membrane vesicles (anta-194/215@Exo) targeting osteosarcoma lung metastatic sites. Intervention with bioengineered exosome mimetics (anta-194/215@Exo) not only impedes osteosarcoma progression but also significantly prolongs the lifespan of tumor-bearing mice. These findings suggest that pulmonary metastatic foci-derived exosomes initiate primary osteosarcoma lung metastasis by transferring the miR-194/215 cluster targeting MARCKS, making the miR-194/215 cluster a promising therapeutic target for inhibiting the progression of patients with osteosarcoma lung metastases.
AbstractList Osteosarcoma, a prevalent primary malignant bone tumor, often presents with lung metastases, severely impacting patient survival rates. Extracellular vesicles, particularly exosomes, play a pivotal role in the formation and progression of osteosarcoma-related pulmonary lesions. However, the communication between primary osteosarcoma and exosome-mediated pulmonary lesions remains obscure, with the potential impact of pulmonary metastatic foci on osteosarcoma progression largely unknown. This study unveils an innovative mechanism by which exosomes originating from osteosarcoma pulmonary metastatic sites transport the miR-194/215 cluster to the primary tumor site. This transportation enhances lung metastatic capability by downregulating myristoylated alanine-rich C-kinase substrate (MARCKS) expression. Addressing this phenomenon, in this study we employ cationic bovine serum albumin (CBSA) to form nanoparticles (CBSA-anta-194/215) electrostatic interaction with antagomir-miR-194/215. These nanoparticles are loaded into nucleic acid-depleted exosomal membrane vesicles (anta-194/215@Exo) targeting osteosarcoma lung metastatic sites. Intervention with bioengineered exosome mimetics (anta-194/215@Exo) not only impedes osteosarcoma progression but also significantly prolongs the lifespan of tumor-bearing mice. These findings suggest that pulmonary metastatic foci-derived exosomes initiate primary osteosarcoma lung metastasis by transferring the miR-194/215 cluster targeting MARCKS, making the miR-194/215 cluster a promising therapeutic target for inhibiting the progression of patients with osteosarcoma lung metastases.
Osteosarcoma, a prevalent primary malignant bone tumor, often presents with lung metastases, severely impacting patient survival rates. Extracellular vesicles, particularly exosomes, play a pivotal role in the formation and progression of osteosarcoma-related pulmonary lesions. However, the communication between primary osteosarcoma and exosome-mediated pulmonary lesions remains obscure, with the potential impact of pulmonary metastatic foci on osteosarcoma progression largely unknown. This study unveils an innovative mechanism by which exosomes originating from osteosarcoma pulmonary metastatic sites transport the miR-194/215 cluster to the primary tumor site. This transportation enhances lung metastatic capability by downregulating myristoylated alanine-rich C-kinase substrate (MARCKS) expression. Addressing this phenomenon, in this study we employ cationic bovine serum albumin (CBSA) to form nanoparticles (CBSA-anta-194/215) via electrostatic interaction with antagomir-miR-194/215. These nanoparticles are loaded into nucleic acid-depleted exosomal membrane vesicles (anta-194/215@Exo) targeting osteosarcoma lung metastatic sites. Intervention with bioengineered exosome mimetics (anta-194/215@Exo) not only impedes osteosarcoma progression but also significantly prolongs the lifespan of tumor-bearing mice. These findings suggest that pulmonary metastatic foci-derived exosomes initiate primary osteosarcoma lung metastasis by transferring the miR-194/215 cluster targeting MARCKS, making the miR-194/215 cluster a promising therapeutic target for inhibiting the progression of patients with osteosarcoma lung metastases.Osteosarcoma, a prevalent primary malignant bone tumor, often presents with lung metastases, severely impacting patient survival rates. Extracellular vesicles, particularly exosomes, play a pivotal role in the formation and progression of osteosarcoma-related pulmonary lesions. However, the communication between primary osteosarcoma and exosome-mediated pulmonary lesions remains obscure, with the potential impact of pulmonary metastatic foci on osteosarcoma progression largely unknown. This study unveils an innovative mechanism by which exosomes originating from osteosarcoma pulmonary metastatic sites transport the miR-194/215 cluster to the primary tumor site. This transportation enhances lung metastatic capability by downregulating myristoylated alanine-rich C-kinase substrate (MARCKS) expression. Addressing this phenomenon, in this study we employ cationic bovine serum albumin (CBSA) to form nanoparticles (CBSA-anta-194/215) via electrostatic interaction with antagomir-miR-194/215. These nanoparticles are loaded into nucleic acid-depleted exosomal membrane vesicles (anta-194/215@Exo) targeting osteosarcoma lung metastatic sites. Intervention with bioengineered exosome mimetics (anta-194/215@Exo) not only impedes osteosarcoma progression but also significantly prolongs the lifespan of tumor-bearing mice. These findings suggest that pulmonary metastatic foci-derived exosomes initiate primary osteosarcoma lung metastasis by transferring the miR-194/215 cluster targeting MARCKS, making the miR-194/215 cluster a promising therapeutic target for inhibiting the progression of patients with osteosarcoma lung metastases.
Osteosarcoma, a prevalent primary malignant bone tumor, often presents with lung metastases, severely impacting patient survival rates. Extracellular vesicles, particularly exosomes, play a pivotal role in the formation and progression of osteosarcoma-related pulmonary lesions. However, the communication between primary osteosarcoma and exosome-mediated pulmonary lesions remains obscure, with the potential impact of pulmonary metastatic foci on osteosarcoma progression largely unknown. This study unveils an innovative mechanism by which exosomes originating from osteosarcoma pulmonary metastatic sites transport the miR-194/215 cluster to the primary tumor site. This transportation enhances lung metastatic capability by downregulating myristoylated alanine-rich C-kinase substrate (MARCKS) expression. Addressing this phenomenon, in this study we employ cationic bovine serum albumin (CBSA) to form nanoparticles (CBSA-anta-194/215) via electrostatic interaction with antagomir-miR-194/215. These nanoparticles are loaded into nucleic acid-depleted exosomal membrane vesicles (anta-194/215@Exo) targeting osteosarcoma lung metastatic sites. Intervention with bioengineered exosome mimetics (anta-194/215@Exo) not only impedes osteosarcoma progression but also significantly prolongs the lifespan of tumor-bearing mice. These findings suggest that pulmonary metastatic foci-derived exosomes initiate primary osteosarcoma lung metastasis by transferring the miR-194/215 cluster targeting MARCKS, making the miR-194/215 cluster a promising therapeutic target for inhibiting the progression of patients with osteosarcoma lung metastases.
Author Meng, Lulu
Luo, Jun
Kong, Lingyi
Zhang, Chao
Tian, Yanyuan
Yu, Pei
Han, Yubao
Han, Chao
Xu, Wenjun
Jin, Zhiwei
Author_xml – sequence: 1
  givenname: Pei
  surname: Yu
  fullname: Yu, Pei
– sequence: 2
  givenname: Yubao
  surname: Han
  fullname: Han, Yubao
– sequence: 3
  givenname: Lulu
  surname: Meng
  fullname: Meng, Lulu
– sequence: 4
  givenname: Yanyuan
  surname: Tian
  fullname: Tian, Yanyuan
– sequence: 5
  givenname: Zhiwei
  surname: Jin
  fullname: Jin, Zhiwei
– sequence: 6
  givenname: Jun
  surname: Luo
  fullname: Luo, Jun
– sequence: 7
  givenname: Chao
  surname: Han
  fullname: Han, Chao
– sequence: 8
  givenname: Wenjun
  surname: Xu
  fullname: Xu, Wenjun
– sequence: 9
  givenname: Lingyi
  orcidid: 0000-0001-9712-2618
  surname: Kong
  fullname: Kong, Lingyi
– sequence: 10
  givenname: Chao
  surname: Zhang
  fullname: Zhang, Chao
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38799644$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1u1DAURrMooqX0BVggL9lk6n8ny2pUoKIIqcDacuzrqUdJPNgOoi_BM-MwbRcssK5kyT7fta7Pq-ZkjjM0zRuCNwQTebnfmEMeNhRTvsGkljxpziglpGUdE6fNRc57XJfElCrxsjllnep7yflZ8_v6V8xxgowcpPATHPIpTuiwjFOcTXpAExSTiynBohxK5WC-N7MFFHOBmE2ycTJoXObdE5pDRsMDKsnM2UNKoV6Ve0BTuGtJzy8pEciOS40nVEzaQVmJz1d3209fXzcvvBkzXDzu583399ffth_b2y8fbrZXt63lUpZWKk-wUp1xTrBOSEfB9qp3pPeYM-PYQEXvO6iYdcwpDk7JgVLMPPRGOnbe3Bz7umj2-pDCVGfV0QT99yCmnTapzjyCpoIpKYF76SmXGA9EmA6cJFZyiq2pvd4dex1S_LFALnoK2cI4mhnikjWr_64EFrKv6NtHdBkmcM8PP_moAD0CNsWcE_hnhGC9utZ7vbrWq2uNSS1ZQ90_IRtWY3GuDsL4v-gfo8mzEg
CitedBy_id crossref_primary_10_1016_j_jbo_2025_100674
crossref_primary_10_1007_s40843_024_2858_8
crossref_primary_10_1016_j_apsb_2024_09_005
crossref_primary_10_1016_j_phrs_2024_107179
crossref_primary_10_1016_j_jconrel_2025_113614
crossref_primary_10_1016_j_ijbiomac_2024_138649
crossref_primary_10_1186_s12943_024_01995_z
crossref_primary_10_1016_j_bcp_2025_116838
Cites_doi 10.1038/nature15756
10.1002/adma.201606209
10.1016/j.bbamcr.2006.07.001
10.1186/s13046-015-0135-8
10.1038/nrclinonc.2011.64
10.1016/j.jconrel.2019.12.005
10.3390/ijms23095196
10.1186/s13046-020-01570-6
10.1016/j.lfs.2019.116771
10.1038/s41388-021-01933-z
10.1038/s41389-020-00280-0
10.1186/s12943-017-0740-6
10.1038/nature15373
10.1016/j.biomaterials.2013.11.083
10.1038/s41419-022-04949-9
10.1002/advs.202207080
10.1016/j.apsb.2021.08.011
10.4149/neo_2017_412
10.1038/s41467-019-09878-4
10.1093/bioinformatics/btt014
10.1038/onc.2013.336
10.1002/jcb.28514
10.1186/s13046-021-01906-w
10.1016/j.celrep.2018.06.103
10.3390/cancers12020459
10.1126/science.368.6495.1150
10.1016/j.jconrel.2021.08.024
10.1158/1078-0432.CCR-11-3091
10.3390/ijms21134633
10.1016/0092-8674(92)90546-O
10.1038/s41419-023-05841-w
10.1038/s41392-021-00501-x
10.1038/s41565-021-00898-0
10.1038/ncb1596
10.1038/nm.4487
10.1186/s12935-021-02257-4
10.1038/nmeth.1294
10.1200/JCO.2014.59.4895
10.1186/s12943-020-01288-1
10.1016/j.cell.2009.11.025
10.1016/j.molcel.2005.03.008
10.1002/advs.202205483
10.1053/j.gastro.2020.05.052
10.1016/j.biotechadv.2018.09.001
10.1158/0008-5472.CAN-08-4783
10.1038/s41392-020-00261-0
10.1158/0008-5472.CAN-16-2529
10.1016/j.cellsig.2010.03.003
10.1016/j.ccr.2014.03.007
10.1002/hep.23311
10.1038/mt.2011.53
10.1002/(SICI)1097-0215(19980302)75:5<774::AID-IJC18>3.0.CO;2-6
10.1038/s41556-018-0256-3
10.1038/nrc3838
10.1038/s41392-020-00414-1
ContentType Journal Article
Copyright 2024 The Authors.
Copyright_xml – notice: 2024 The Authors.
DBID AAYXX
CITATION
NPM
7X8
DOA
DOI 10.1016/j.apsb.2024.01.016
DatabaseName CrossRef
PubMed
MEDLINE - Academic
DOAJ: Directory of Open Access Journal (DOAJ)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EndPage 2056
ExternalDocumentID oai_doaj_org_article_253766e4f6f24600b15a8ed61c6420ca
38799644
10_1016_j_apsb_2024_01_016
Genre Journal Article
GroupedDBID ---
--K
-05
-0E
-SE
-S~
0R~
1~5
4.4
457
4G.
53G
5VR
5VS
7-5
92M
9D9
9DE
AAEDT
AAEDW
AAIKJ
AALRI
AAXUO
AAYWO
AAYXX
ABKZE
ABMAC
ACGFS
ACVFH
ADBBV
ADCNI
ADEZE
ADRAZ
ADVLN
AEUPX
AEXQZ
AFPUW
AFUIB
AGHFR
AIGII
AITUG
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
APXCP
BAWUL
BCNDV
CAJEE
CCEZO
CIEJG
CITATION
DIK
EBS
EJD
FDB
GROUPED_DOAJ
GX1
HH5
HYE
HZ~
IPNFZ
IXB
JUIAU
KQ8
M41
M48
O-L
O9-
OK1
Q--
R-E
RIG
ROL
RPM
RT5
SES
SSZ
T8U
U1F
U1G
U5E
U5O
XH2
~NG
0SF
6I.
AACTN
AAFTH
AAXDM
NCXOZ
NPM
Q-4
7X8
ID FETCH-LOGICAL-c466t-67f10778add53856d2ec979d19f043ad3b259f8e7f1cd3d74ed76b2203fe9a6d3
IEDL.DBID M48
ISSN 2211-3835
IngestDate Wed Aug 27 00:49:42 EDT 2025
Fri Jul 11 10:36:37 EDT 2025
Thu Jan 02 22:35:11 EST 2025
Tue Jul 01 01:53:13 EDT 2025
Thu Apr 24 23:03:07 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Bioengineered exosome mimetics
Lung metastasis
Exosome
Osteosarcoma
Epithelial–mesenchymal transition
miR-194/215 cluster
Lung–bone transmission
Vasculogenic mimicry
Language English
License 2024 The Authors.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c466t-67f10778add53856d2ec979d19f043ad3b259f8e7f1cd3d74ed76b2203fe9a6d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-9712-2618
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1016/j.apsb.2024.01.016
PMID 38799644
PQID 3060750569
PQPubID 23479
PageCount 18
ParticipantIDs doaj_primary_oai_doaj_org_article_253766e4f6f24600b15a8ed61c6420ca
proquest_miscellaneous_3060750569
pubmed_primary_38799644
crossref_primary_10_1016_j_apsb_2024_01_016
crossref_citationtrail_10_1016_j_apsb_2024_01_016
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-05-00
2024-May
20240501
2024-05-01
PublicationDateYYYYMMDD 2024-05-01
PublicationDate_xml – month: 05
  year: 2024
  text: 2024-05-00
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Acta pharmaceutica Sinica. B
PublicationTitleAlternate Acta Pharm Sin B
PublicationYear 2024
Publisher Elsevier
Publisher_xml – name: Elsevier
References Keklikoglou (10.1016/j.apsb.2024.01.016_bib23) 2019; 21
Chen (10.1016/j.apsb.2024.01.016_bib38) 2014; 33
Wang (10.1016/j.apsb.2024.01.016_bib2) 2019; 234
Yu (10.1016/j.apsb.2024.01.016_bib33) 2021; 40
Yan (10.1016/j.apsb.2024.01.016_bib6) 2022; 12
Shen (10.1016/j.apsb.2024.01.016_bib5) 2021; 6
Pei (10.1016/j.apsb.2024.01.016_bib27) 2021; 338
Wei (10.1016/j.apsb.2024.01.016_bib34) 2021; 20
Yamaguchi (10.1016/j.apsb.2024.01.016_bib47) 2007; 1773
Chen (10.1016/j.apsb.2024.01.016_bib14) 2021; 11
Isakoff (10.1016/j.apsb.2024.01.016_bib1) 2015; 33
Armacki (10.1016/j.apsb.2024.01.016_bib25) 2020; 159
Gao (10.1016/j.apsb.2024.01.016_bib39) 2005; 18
Dai (10.1016/j.apsb.2024.01.016_bib12) 2020; 5
Kovar (10.1016/j.apsb.2024.01.016_bib7) 2018; 24
Han (10.1016/j.apsb.2024.01.016_bib57) 2023; 10
Zhang (10.1016/j.apsb.2024.01.016_bib4) 2018; 24
Chao (10.1016/j.apsb.2024.01.016_bib9) 2020; 12
Li (10.1016/j.apsb.2024.01.016_bib48) 2023; 14
Zhao (10.1016/j.apsb.2024.01.016_bib42) 2020; 318
Osaki (10.1016/j.apsb.2024.01.016_bib37) 2011; 19
Santos (10.1016/j.apsb.2024.01.016_bib56) 2020; 368
Zhong (10.1016/j.apsb.2024.01.016_bib11) 2021; 6
Luan (10.1016/j.apsb.2024.01.016_bib24) 2021; 40
Pena (10.1016/j.apsb.2024.01.016_bib26) 2009; 6
Kulkarni (10.1016/j.apsb.2024.01.016_bib51) 2021; 16
Chen (10.1016/j.apsb.2024.01.016_bib18) 2010; 22
Zeng (10.1016/j.apsb.2024.01.016_bib10) 2023; 10
Micallef (10.1016/j.apsb.2024.01.016_bib19) 2009; 69
Yokoyama (10.1016/j.apsb.2024.01.016_bib21) 1998; 75
Hu (10.1016/j.apsb.2024.01.016_bib36) 2015; 34
Kim (10.1016/j.apsb.2024.01.016_bib46) 2009; 139
Pidikova (10.1016/j.apsb.2024.01.016_bib15) 2020; 21
Dehaini (10.1016/j.apsb.2024.01.016_bib40) 2017; 29
Hoshino (10.1016/j.apsb.2024.01.016_bib45) 2015; 527
Tan (10.1016/j.apsb.2024.01.016_bib53) 2020; 39
Jarboe (10.1016/j.apsb.2024.01.016_bib20) 2012; 18
Patel (10.1016/j.apsb.2024.01.016_bib55) 2018; 36
Ren (10.1016/j.apsb.2024.01.016_bib29) 2019; 120
Tian (10.1016/j.apsb.2024.01.016_bib52) 2014; 35
Sun (10.1016/j.apsb.2024.01.016_bib30) 2010; 51
Kansara (10.1016/j.apsb.2024.01.016_bib3) 2014; 14
Hu (10.1016/j.apsb.2024.01.016_bib41) 2015; 526
Li (10.1016/j.apsb.2024.01.016_bib31) 2016; 6
Lee (10.1016/j.apsb.2024.01.016_bib8) 2019; 10
Aderem (10.1016/j.apsb.2024.01.016_bib17) 1992; 71
Xie (10.1016/j.apsb.2024.01.016_bib16) 2013; 29
Zang (10.1016/j.apsb.2024.01.016_bib50) 2017; 64
García-Heredia (10.1016/j.apsb.2024.01.016_bib28) 2020; 9
Das (10.1016/j.apsb.2024.01.016_bib49) 2017; 77
Dioufa (10.1016/j.apsb.2024.01.016_bib44) 2017; 16
Hua (10.1016/j.apsb.2024.01.016_bib22) 2022; 23
Comen (10.1016/j.apsb.2024.01.016_bib43) 2011; 8
Liu (10.1016/j.apsb.2024.01.016_bib13) 2021; 21
Valadi (10.1016/j.apsb.2024.01.016_bib35) 2007; 9
Zhou (10.1016/j.apsb.2024.01.016_bib32) 2014; 25
Tuo (10.1016/j.apsb.2024.01.016_bib54) 2022; 13
References_xml – volume: 527
  start-page: 329
  year: 2015
  ident: 10.1016/j.apsb.2024.01.016_bib45
  article-title: Tumour exosome integrins determine organotropic metastasis
  publication-title: Nature
  doi: 10.1038/nature15756
– volume: 29
  year: 2017
  ident: 10.1016/j.apsb.2024.01.016_bib40
  article-title: Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization
  publication-title: Adv Mater
  doi: 10.1002/adma.201606209
– volume: 1773
  start-page: 642
  year: 2007
  ident: 10.1016/j.apsb.2024.01.016_bib47
  article-title: Regulation of the actin cytoskeleton in cancer cell migration and invasion
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbamcr.2006.07.001
– volume: 34
  start-page: 22
  year: 2015
  ident: 10.1016/j.apsb.2024.01.016_bib36
  article-title: DEC2 expression is positively correlated with HIF-1 activation and the invasiveness of human osteosarcomas
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-015-0135-8
– volume: 8
  start-page: 369
  year: 2011
  ident: 10.1016/j.apsb.2024.01.016_bib43
  article-title: Clinical implications of cancer self-seeding
  publication-title: Nat Rev Clin Oncol
  doi: 10.1038/nrclinonc.2011.64
– volume: 318
  start-page: 1
  year: 2020
  ident: 10.1016/j.apsb.2024.01.016_bib42
  article-title: Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis
  publication-title: J Control Release
  doi: 10.1016/j.jconrel.2019.12.005
– volume: 23
  start-page: 5196
  year: 2022
  ident: 10.1016/j.apsb.2024.01.016_bib22
  article-title: Small extracellular vesicles containing miR-34c derived from bone marrow mesenchymal stem cells regulates epithelial sodium channel via targeting MARCKS
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms23095196
– volume: 39
  start-page: 67
  year: 2020
  ident: 10.1016/j.apsb.2024.01.016_bib53
  article-title: Exosomal miRNAs in tumor microenvironment
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-020-01570-6
– volume: 234
  year: 2019
  ident: 10.1016/j.apsb.2024.01.016_bib2
  article-title: MAT1 facilitates the lung metastasis of osteosarcoma through upregulation of AKT1 expression
  publication-title: Life Sci
  doi: 10.1016/j.lfs.2019.116771
– volume: 40
  start-page: 5262
  year: 2021
  ident: 10.1016/j.apsb.2024.01.016_bib33
  article-title: The Chk2–PKM2 axis promotes metabolic control of vasculogenic mimicry formation in p53-mutated triple-negative breast cancer
  publication-title: Oncogene
  doi: 10.1038/s41388-021-01933-z
– volume: 9
  start-page: 96
  year: 2020
  ident: 10.1016/j.apsb.2024.01.016_bib28
  article-title: Breast tumor cells promotes the horizontal propagation of EMT, stemness, and metastasis by transferring the MAP17 protein between subsets of neoplastic cells
  publication-title: Oncogenesis
  doi: 10.1038/s41389-020-00280-0
– volume: 16
  start-page: 172
  year: 2017
  ident: 10.1016/j.apsb.2024.01.016_bib44
  article-title: Bi-directional exosome-driven intercommunication between the hepatic niche and cancer cells
  publication-title: Mol Cancer
  doi: 10.1186/s12943-017-0740-6
– volume: 526
  start-page: 118
  year: 2015
  ident: 10.1016/j.apsb.2024.01.016_bib41
  article-title: Nanoparticle biointerfacing by platelet membrane cloaking
  publication-title: Nature
  doi: 10.1038/nature15373
– volume: 35
  start-page: 2383
  year: 2014
  ident: 10.1016/j.apsb.2024.01.016_bib52
  article-title: A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2013.11.083
– volume: 13
  start-page: 539
  year: 2022
  ident: 10.1016/j.apsb.2024.01.016_bib54
  article-title: Roles of exosomal circRNAs in tumour immunity and cancer progression
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-022-04949-9
– volume: 10
  year: 2023
  ident: 10.1016/j.apsb.2024.01.016_bib57
  article-title: Bone lesion-derived extracellular vesicles fuel prometastatic cascades in hepatocellular carcinoma by transferring ALKBH5-targeting miR-3190-5p
  publication-title: Adv Sci
  doi: 10.1002/advs.202207080
– volume: 12
  start-page: 939
  year: 2022
  ident: 10.1016/j.apsb.2024.01.016_bib6
  article-title: Inhibiting collagen I production and tumor cell colonization in the lung via miR-29a-3p loading of exosome-/liposome-based nanovesicles
  publication-title: Acta Pharm Sin B
  doi: 10.1016/j.apsb.2021.08.011
– volume: 64
  start-page: 579
  year: 2017
  ident: 10.1016/j.apsb.2024.01.016_bib50
  article-title: miR-215 promotes cell migration and invasion of gastric cancer cell lines by targeting FOXO1
  publication-title: Neoplasma
  doi: 10.4149/neo_2017_412
– volume: 10
  start-page: 2131
  year: 2019
  ident: 10.1016/j.apsb.2024.01.016_bib8
  article-title: Collagen-rich airway smooth muscle cells are a metastatic niche for tumor colonization in the lung
  publication-title: Nat Commun
  doi: 10.1038/s41467-019-09878-4
– volume: 29
  start-page: 638
  year: 2013
  ident: 10.1016/j.apsb.2024.01.016_bib16
  article-title: miRCancer: a microRNA-cancer association database constructed by text mining on literature
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btt014
– volume: 33
  start-page: 3696
  year: 2014
  ident: 10.1016/j.apsb.2024.01.016_bib38
  article-title: A peptide that inhibits function of myristoylated alanine-rich C kinase substrate (MARCKS) reduces lung cancer metastasis
  publication-title: Oncogene
  doi: 10.1038/onc.2013.336
– volume: 120
  start-page: 12473
  year: 2019
  ident: 10.1016/j.apsb.2024.01.016_bib29
  article-title: Expression profiling of long noncoding RNAs associated with vasculogenic mimicry in osteosarcoma
  publication-title: J Cell Biochem
  doi: 10.1002/jcb.28514
– volume: 40
  start-page: 107
  year: 2021
  ident: 10.1016/j.apsb.2024.01.016_bib24
  article-title: Exosomal miR-106b-5p derived from melanoma cell promotes primary melanocytes epithelial–mesenchymal transition through targeting EphA4
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-021-01906-w
– volume: 24
  start-page: 1266
  year: 2018
  ident: 10.1016/j.apsb.2024.01.016_bib4
  article-title: Adaptive fibrogenic reprogramming of osteosarcoma stem cells promotes metastatic growth
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2018.06.103
– volume: 12
  start-page: 459
  year: 2020
  ident: 10.1016/j.apsb.2024.01.016_bib9
  article-title: CXCL1/CXCR2 paracrine axis contributes to lung metastasis in osteosarcoma
  publication-title: Cancers
  doi: 10.3390/cancers12020459
– volume: 368
  start-page: 1150
  year: 2020
  ident: 10.1016/j.apsb.2024.01.016_bib56
  article-title: No place like home
  publication-title: Science
  doi: 10.1126/science.368.6495.1150
– volume: 338
  start-page: 253
  year: 2021
  ident: 10.1016/j.apsb.2024.01.016_bib27
  article-title: Exosome membrane-modified M2 macrophages targeted nanomedicine: treatment for allergic asthma
  publication-title: J Control Release
  doi: 10.1016/j.jconrel.2021.08.024
– volume: 18
  start-page: 3030
  year: 2012
  ident: 10.1016/j.apsb.2024.01.016_bib20
  article-title: MARCKS regulates growth and radiation sensitivity and is a novel prognostic factor for glioma
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-11-3091
– volume: 21
  start-page: 4633
  year: 2020
  ident: 10.1016/j.apsb.2024.01.016_bib15
  article-title: miRNA clusters with down-regulated expression in human colorectal cancer and their regulation
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms21134633
– volume: 71
  start-page: 713
  year: 1992
  ident: 10.1016/j.apsb.2024.01.016_bib17
  article-title: The marcks brothers—a family of protein-kinase-C substrates
  publication-title: Cell
  doi: 10.1016/0092-8674(92)90546-O
– volume: 14
  start-page: 335
  year: 2023
  ident: 10.1016/j.apsb.2024.01.016_bib48
  article-title: RIPK1-dependent necroptosis promotes vasculogenic mimicry formation via eIF4E in triple-negative breast cancer
  publication-title: Cell Death Dis
  doi: 10.1038/s41419-023-05841-w
– volume: 6
  start-page: 115
  year: 2021
  ident: 10.1016/j.apsb.2024.01.016_bib5
  article-title: Targeting Erbin in B cells for therapy of lung metastasis of colorectal cancer
  publication-title: Signal Transduct Targeted Ther
  doi: 10.1038/s41392-021-00501-x
– volume: 16
  start-page: 630
  year: 2021
  ident: 10.1016/j.apsb.2024.01.016_bib51
  article-title: The current landscape of nucleic acid therapeutics
  publication-title: Nat Nanotechnol
  doi: 10.1038/s41565-021-00898-0
– volume: 9
  start-page: 654
  year: 2007
  ident: 10.1016/j.apsb.2024.01.016_bib35
  article-title: Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb1596
– volume: 6
  year: 2016
  ident: 10.1016/j.apsb.2024.01.016_bib31
  article-title: Hypoxia-induced vasculogenic mimicry formation in human colorectal cancer cells: involvement of HIF-1α, Claudin-4, and E-cadherin and Vimentin
  publication-title: Sci Rep
– volume: 24
  start-page: 126
  year: 2018
  ident: 10.1016/j.apsb.2024.01.016_bib7
  article-title: Selective enhancer changes in osteosarcoma lung metastasis
  publication-title: Nat Med
  doi: 10.1038/nm.4487
– volume: 21
  start-page: 541
  year: 2021
  ident: 10.1016/j.apsb.2024.01.016_bib13
  article-title: Exosomal transfer of miR-769-5p promotes osteosarcoma proliferation and metastasis by targeting DUSP16
  publication-title: Cancer Cell Int
  doi: 10.1186/s12935-021-02257-4
– volume: 6
  start-page: 139
  year: 2009
  ident: 10.1016/j.apsb.2024.01.016_bib26
  article-title: miRNA in situ hybridization in formaldehyde and EDC-fixed tissues
  publication-title: Nat Methods
  doi: 10.1038/nmeth.1294
– volume: 33
  start-page: 3029
  year: 2015
  ident: 10.1016/j.apsb.2024.01.016_bib1
  article-title: Osteosarcoma: current treatment and a collaborative pathway to success
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2014.59.4895
– volume: 20
  start-page: 7
  year: 2021
  ident: 10.1016/j.apsb.2024.01.016_bib34
  article-title: Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments
  publication-title: Mol Cancer
  doi: 10.1186/s12943-020-01288-1
– volume: 139
  start-page: 1315
  year: 2009
  ident: 10.1016/j.apsb.2024.01.016_bib46
  article-title: Tumor self-seeding by circulating cancer cells
  publication-title: Cell
  doi: 10.1016/j.cell.2009.11.025
– volume: 18
  start-page: 13
  year: 2005
  ident: 10.1016/j.apsb.2024.01.016_bib39
  article-title: PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth
  publication-title: Mol Cell
  doi: 10.1016/j.molcel.2005.03.008
– volume: 10
  year: 2023
  ident: 10.1016/j.apsb.2024.01.016_bib10
  article-title: Targeting the lysosomal degradation of Rab22a-NeoF1 fusion protein for osteosarcoma lung metastasis
  publication-title: Adv Sci
  doi: 10.1002/advs.202205483
– volume: 159
  start-page: 1019
  year: 2020
  ident: 10.1016/j.apsb.2024.01.016_bib25
  article-title: Protein kinase D1, reduced in human pancreatic tumors, increases secretion of small extracellular vesicles from cancer cells that promote metastasis to lung in mice
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2020.05.052
– volume: 36
  start-page: 2051
  year: 2018
  ident: 10.1016/j.apsb.2024.01.016_bib55
  article-title: Towards rationally designed biomanufacturing of therapeutic extracellular vesicles: impact of the bioproduction microenvironment
  publication-title: Biotechnol Adv
  doi: 10.1016/j.biotechadv.2018.09.001
– volume: 69
  start-page: 7548
  year: 2009
  ident: 10.1016/j.apsb.2024.01.016_bib19
  article-title: Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-08-4783
– volume: 5
  start-page: 145
  year: 2020
  ident: 10.1016/j.apsb.2024.01.016_bib12
  article-title: Exosomes: key players in cancer and potential therapeutic strategy
  publication-title: Signal Transduct Targeted Ther
  doi: 10.1038/s41392-020-00261-0
– volume: 77
  start-page: 1021
  year: 2017
  ident: 10.1016/j.apsb.2024.01.016_bib49
  article-title: MicroRNA-194 promotes prostate cancer metastasis by inhibiting SOCS2
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-16-2529
– volume: 22
  start-page: 1097
  year: 2010
  ident: 10.1016/j.apsb.2024.01.016_bib18
  article-title: PhosphoMARCKS drives motility of mouse melanoma cells
  publication-title: Cell Signal
  doi: 10.1016/j.cellsig.2010.03.003
– volume: 25
  start-page: 501
  year: 2014
  ident: 10.1016/j.apsb.2024.01.016_bib32
  article-title: Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2014.03.007
– volume: 51
  start-page: 545
  year: 2010
  ident: 10.1016/j.apsb.2024.01.016_bib30
  article-title: Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry
  publication-title: Hepatology
  doi: 10.1002/hep.23311
– volume: 19
  start-page: 1123
  year: 2011
  ident: 10.1016/j.apsb.2024.01.016_bib37
  article-title: MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression
  publication-title: Mol Ther
  doi: 10.1038/mt.2011.53
– volume: 75
  start-page: 774
  year: 1998
  ident: 10.1016/j.apsb.2024.01.016_bib21
  article-title: PMA-induced reduction in invasiveness is associated with hyperphosphorylation of MARCKS and talin in invasive bladder cancer cells
  publication-title: Int J Cancer
  doi: 10.1002/(SICI)1097-0215(19980302)75:5<774::AID-IJC18>3.0.CO;2-6
– volume: 11
  year: 2021
  ident: 10.1016/j.apsb.2024.01.016_bib14
  article-title: miR-135a reduces osteosarcoma pulmonary metastasis by targeting both BMI1 and KLF4
  publication-title: Front Oncol
– volume: 21
  start-page: 190
  year: 2019
  ident: 10.1016/j.apsb.2024.01.016_bib23
  article-title: Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models
  publication-title: Nat Cell Biol
  doi: 10.1038/s41556-018-0256-3
– volume: 14
  start-page: 722
  year: 2014
  ident: 10.1016/j.apsb.2024.01.016_bib3
  article-title: Translational biology of osteosarcoma
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc3838
– volume: 6
  start-page: 59
  year: 2021
  ident: 10.1016/j.apsb.2024.01.016_bib11
  article-title: Rab22a-NeoF1 fusion protein promotes osteosarcoma lung metastasis through its secretion into exosomes
  publication-title: Signal Transduct Targeted Ther
  doi: 10.1038/s41392-020-00414-1
SSID ssj0000602275
Score 2.335926
Snippet Osteosarcoma, a prevalent primary malignant bone tumor, often presents with lung metastases, severely impacting patient survival rates. Extracellular vesicles,...
SourceID doaj
proquest
pubmed
crossref
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
StartPage 2039
SubjectTerms Epithelial–mesenchymal transition
Exosome
Lung metastasis
Lung–bone transmission
miR-194/215 cluster
Vasculogenic mimicry
SummonAdditionalLinks – databaseName: DOAJ: Directory of Open Access Journal (DOAJ)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlp15Km762L6ZQcmlMbFmW7GMaEkJLSkgTyM3oZbpl114ib-j-ifzmzFjezV7aXgo-2WMkW_P4Bs18YuxTiT7flkolRqUiETpDm0sd2lXlmiyzWquBeP7suzy9El-vi-uto76oJizSA8cfd8CJb0R60ciGC4zOJit06R2OgMg5tQM0wpi3lUxFH0zUeFS_yDnx9CHOGDtmYnGXXgSDySEXA2cnHXa-FZUG8v4_I84h8pw8ZU9GyAiHcarP2CPf7rK988g5vdqHy4cWqrAPe3D-wEa9es7ujn93oZv7AA6V7dY7oI4SWCxnqID6ZgVz32tqK5paoJ3kAL79SaoA1P7RBTSEbq5hhk5hLRqmAcwK-gHzErMjPkIcCfPpRZJV4gDjO9jZkigYIFaak8TZ4cXRtx8v2NXJ8eXRaTIewpBYIWWfSNVghqhK9IPoGwvpuLeVqlxWNanItcsNJlBN6VHMutwp4Z2ShvM0b3ylpctfsp22a_1rBkaawtvCCVMa4dK8FLYp0MnkTnICCxOWrRehtiNDOR2UMavXpWi_alq4mhauTjO85IR93ryziPwcf5X-Qmu7kSRu7eEGalw9alz9L42bsI9rzajRFmmDRbe-W4Ya0y9CYIWsJuxVVJnNUHmpMLUU4s3_mMJb9pi-KhZevmM7_c3Sv0dw1JsPgx3cA6GxCpk
  priority: 102
  providerName: Directory of Open Access Journals
Title Exosomes derived from pulmonary metastatic sites enhance osteosarcoma lung metastasis by transferring the miR-194/215 cluster targeting MARCKS
URI https://www.ncbi.nlm.nih.gov/pubmed/38799644
https://www.proquest.com/docview/3060750569
https://doaj.org/article/253766e4f6f24600b15a8ed61c6420ca
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9RAFB5qffFFar1t1TKC9MVGc5nMJA9F2tJSLCu1dqFvYW6pK9lk3cmW5k_4mz0nl12EKghhIdmzSdhzme8k53yHkHcJxHydCOEp4TOPyQB8zjfgV6nJg0BLKVri-fEXfjZhn6_j6w0yjDvq_0B3b2qH86Qmi-LD3c_mEzj8wbpWS86dglwvZC0FZ8AfkIewMgmcaDDu4X4XmZEwD6sawxDZ-wB99H0095_mj7WqpfT_Ow5t16PTLfK4B5L0sNP8E7Jhy22yd9ExUTf79GrdWOX26R69WHNUN0_Jr5O7ylUz66gBE7y1hmKfCZ0vCzBLuWjozNYSm42mmuL7ZUdt-R0NhGJTSOXAPaqZpAWEikHUTR1VDa1bJIx8j_AVoEs6m156Qco-wqpPdbFEYgba1Z-jxPjw8vj82zMyOT25Oj7z-tEMnmac1x4XOeSNIoHoCBEz5ia0OhWpCdLcZ5E0kYK0Kk8siGkTGcGsEVyFoR_lNpXcRM_JZlmV9iWhiqvY6tgwlShm_ChhOo8h9ESGhwghRiQYlJDpnrccx2cU2VCg9iNDxWWouMwPYOMj8n71m3nH2vFP6SPU7UoSGbfbA9XiJusdOAuR94ZblvM8ZIASVRDLxBqwdMjgfC1H5O1gGRl4KL52kaWtli6DpAxxWczTEXnRmczqUlEiIOFkbOe_bvgVeYR7Xd3la7JZL5b2DWCjWu22zxTg8_xrstsa_28JAQ1V
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exosomes+derived+from+pulmonary+metastatic+sites+enhance+osteosarcoma+lung+metastasis+by+transferring+the+miR-194%2F215+cluster+targeting+MARCKS&rft.jtitle=Acta+pharmaceutica+Sinica.+B&rft.au=Yu%2C+Pei&rft.au=Han%2C+Yubao&rft.au=Meng%2C+Lulu&rft.au=Tian%2C+Yanyuan&rft.date=2024-05-01&rft.issn=2211-3835&rft.volume=14&rft.issue=5&rft.spage=2039&rft.epage=2056&rft_id=info:doi/10.1016%2Fj.apsb.2024.01.016&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_apsb_2024_01_016
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2211-3835&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2211-3835&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2211-3835&client=summon